Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 21, 1986 - Issue sup119
Submit an article Journal homepage
67
Views
107
CrossRef citations to date
0
Altmetric
Original Article

Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of Somatostatin

J. Pless Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
W. Bauer Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
U. Briner Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
W. Doepfner Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
P. Marbach Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
R. Maurer Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
T. J. Petcher Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
,
J. -C. Reubi Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
&
J. Vonderscher Pharmaceutical Division, Preclinical Research Dept., Sandoz Ltd, Basle, Switzerland
 show all
Pages 54-64 | Published online: 08 Jul 2009

Citations (107)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kjell Öberg, Lone Astrup, Barbro Eriksson, Sture E. Falkmer, Ursula G. Falkmer, Jens Gustafsen, Caj Haglund, Ulrich Knigge, Morten H. Vatn & Matti Välimäki. (2004) Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) Part I—General Overview. Acta Oncologica 43:7, pages 617-625.
Read now
Lowell Anthony, David Johnson, Kenneth Hande, Max Shaff, Sheilah Winn, Mary Krozely & John Oates. (1993) Somatostatin Analogue Phase I Trials in Neuroendocrine Neoplasms. Acta Oncologica 32:2, pages 217-223.
Read now
K. Kimura. (1993) Effect of a Somatostatin Analogue (SMS 201–995) on Antral Gastrin Cell Hyperplasia and Hypergastrinemia Induced by a Histamine H2-Receptor Antagonist. Scandinavian Journal of Gastroenterology 28:5, pages 413-417.
Read now
K. Ouberg & B. Eriksson. (1989) Medical Treatment of Neuroendocrine Gut and Pancreatic Tumors. Acta Oncologica 28:3, pages 425-431.
Read now

Articles from other publishers (103)

Biagio Todaro, Elisa Ottalagana, Stefano Luin & Melissa Santi. (2023) Targeting Peptides: The New Generation of Targeted Drug Delivery Systems. Pharmaceutics 15:6, pages 1648.
Crossref
Jonas Lins, Yuliya A. Miloslavina, Stefania C. Carrara, Lorenz Rösler, Sarah Hofmann, Kevin Herr, Franziska Theiß, Laura Wienands, Olga Avrutina, Harald Kolmar & Gerd Buntkowsky. (2023) Parahydrogen-induced polarization allows 2000-fold signal enhancement in biologically active derivatives of the peptide-based drug octreotide. Scientific Reports 13:1.
Crossref
Thomas Kremsmayr, Aws Aljnabi, Juan B. Blanco-Canosa, Hue N. T. Tran, Nayara Braga Emidio & Markus Muttenthaler. (2022) On the Utility of Chemical Strategies to Improve Peptide Gut Stability. Journal of Medicinal Chemistry 65:8, pages 6191-6206.
Crossref
Eleni Doulou, Marina Kalomiraki, Anthi Parla, Kyriaki Thermos, Nikos A. Chaniotakis & Irene Panderi. (2021) Hydrophilic Interaction Liquid Chromatography Coupled with Fluorescence Detection (HILIC-FL) for the Quantitation of Octreotide in Injection Forms. Analytica 2:4, pages 121-129.
Crossref
Zongmin Zhao, Anvay Ukidve, Jayoung Kim & Samir Mitragotri. (2020) Targeting Strategies for Tissue-Specific Drug Delivery. Cell 181:1, pages 151-167.
Crossref
Zhuxuan Jiang, Juan Guan, Jun Qian & Changyou Zhan. (2019) Peptide ligand-mediated targeted drug delivery of nanomedicines. Biomaterials Science 7:2, pages 461-471.
Crossref
Anna Tornesello, Luigi Buonaguro, Maria Tornesello & Franco Buonaguro. (2017) New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology. Molecules 22:8, pages 1282.
Crossref
Chunli Wang, Xin Zhao & Shengyi You. (2017) Efficacy of the prophylactic use of octreotide for the prevention of complications after pancreatic resection. Medicine 96:29, pages e7500.
Crossref
Kjell Öberg. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric 2615 2627.e3 .
Kouichi Tanabe, Junko Wada, Jun Ohkubo, Atsumi Nitta, Tomoaki Ikezaki, Miyako Takeuchi, Aya Handa, Mai Tanaka, Nozomu Murakami, Tatsuhiko Kashii & Hidenori Kitazawa. (2015) Stability of octreotide acetate decreases in a sodium bisulfate concentration-dependent manner: compatibility study with morphine and metoclopramide injections. European Journal of Hospital Pharmacy 22:3, pages 171-175.
Crossref
Renata Mikołajczak & Alberto Signore. 2015. Somatostatin Analogues. Somatostatin Analogues 35 54 .
Jean Claude Reubi & Agnes Schonbrunn. (2013) Illuminating somatostatin analog action at neuroendocrine tumor receptors. Trends in Pharmacological Sciences 34:12, pages 676-688.
Crossref
Sarmistha Banerjee, Rajat Kumar Das & Bernard H. Shapiro. (2013) Growth hormone-independent suppression of growth hormone-dependent female isoforms of cytochrome P450 by the somatostatin analog octreotide. European Journal of Pharmacology 715:1-3, pages 256-261.
Crossref
Kouichi Tanabe, Jun Ohkubo, Tomoaki Ikezaki, Shohei Kitayama, Yuki Tsuneda, Atsumi Nitta, Lisa Imamura, Hideto To, Masanari Shimada, Nozomu Murakami & Hidenori Kitazawa. (2013) Effect of sodium bisulphate on the stability of octreotide acetate: compatibility study with dexamethasone injection. Palliative Care Research 8:2, pages 177-183.
Crossref
Attila Tóth, T. Henter & L. Détári. (2012) Basal forebrain administration of the somatostatin-analog octreotide does not affect cortical EEG in urethane anaesthetized rats. Acta Physiologica Hungarica 99:4, pages 460-471.
Crossref
Johannes Parmentier, Bernhard Thewes, Felix Gropp & Gert Fricker. (2011) Oral peptide delivery by tetraether lipid liposomes. International Journal of Pharmaceutics 415:1-2, pages 150-157.
Crossref
Christiane Damgé, Jacky Vonderscher, Peter Marbach & Michel Pinget. (1997) Poly(alkyl cyanoacrylate) Nanocapsules as a Delivery System in the Rat for Octreotide, a Long-acting Somatostatin Analogue. Journal of Pharmacy and Pharmacology 49:10, pages 949-954.
Crossref
Chunhui Wang, Hua Xu, Huacong Chen, Jing Li, Bo Zhang, Chengwei TangFayez K. Ghishan. (2011) Somatostatin stimulates intestinal NHE8 expression via p38 MAPK pathway. American Journal of Physiology-Cell Physiology 300:2, pages C375-C382.
Crossref
Jonathan Strosberg. 2011. Neuroendocrine Tumors. Neuroendocrine Tumors 101 115 .
John LyonsIIIIII, Catherine T. Anthony & Eugene A. Woltering. (2010) The Role of Angiogenesis in Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 39:4, pages 839-852.
Crossref
Richard H. Kimura, Zheng Miao, Zhen Cheng, Sanjiv S. Gambhir & Jennifer R. Cochran. (2010) A Dual-Labeled Knottin Peptide for PET and Near-Infrared Fluorescence Imaging of Integrin Expression in Living Subjects. Bioconjugate Chemistry 21:3, pages 436-444.
Crossref
Barbro Eriksson & Kjell Öberg. 2010. Endocrinology. Endocrinology 2774 2786 .
Seema Saksena, Saritha Theegala, Nikhil Bansal, Ravinder K. Gill, Sangeeta Tyagi, Waddah A. Alrefai, Krishnamurthy Ramaswamy & Pradeep K. Dudeja. (2009) Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 297:5, pages G878-G885.
Crossref
David C. Metz & Robert T. Jensen. (2008) Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors. Gastroenterology 135:5, pages 1469-1492.
Crossref
Mitsuyoshi Suzuki, Oto Takata, Sachi Sakaguchi, Junya Fujimura, Masahiro Saito & Toshiaki Shimizu. (2008) Retherapy using l-asparaginase with octreotide in a patient recovering from l-asparaginase-induced pancreatitis. Experimental Hematology 36:3, pages 253-254.
Crossref
Mitsuyoshi Suzuki, Toshiaki Shimizu, Takahiro Kudo, Hiromichi Shoji, Yoshikazu Ohtsuka & Yuichiro Yamashiro. (2008) Octreotide prevents l-asparaginase–induced pancreatic injury in rats. Experimental Hematology 36:2, pages 172-180.
Crossref
Feng Gao. (2006) Effect of somatostatin analogue octreotide injected into the third cerebral ventricle on pentagastrin-induced gastric acid secretion in rats. World Journal of Gastroenterology 12:17, pages 2767.
Crossref
S S Sikora & M C Posner. (1995) Management of the pancreatic stump following pancreaticoduodenectomy. British Journal of Surgery 82:12, pages 1590-1597.
Crossref
P Pederzoli, C Bassi, M Falconi & M G Camboni. (1994) Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. British Journal of Surgery 81:2, pages 265-269.
Crossref
B Ahrén, K-G Tranberg & S Bengmark. (1988) Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995. British Journal of Surgery 75:7, pages 718-718.
Crossref
F Gibril & R.T Jensen. (2004) Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. Digestive and Liver Disease 36, pages S106-S120.
Crossref
Ildiko Hajdu, Eva Szentirmai, Ferenc ObalJr.Jr. & James M. Krueger. (2003) Different brain structures mediate drinking and sleep suppression elicited by the somatostatin analog, octreotide, in rats. Brain Research 994:1, pages 115-123.
Crossref
Eugene A. Woltering. (2003) Development of Targeted Somatostatin-Based Antiangiogenic Therapy: A Review and Future Perspectives. Cancer Biotherapy and Radiopharmaceuticals 18:4, pages 601-609.
Crossref
Mitsushi Shimada, Yukari Date, Muhtashan S Mondal, Koji Toshinai, Takuya Shimbara, Kyoko Fukunaga, Noboru Murakami, Mikiya Miyazato, Kenji Kangawa, Hironobu Yoshimatsu, Hisayuki Matsuo & Masamitsu Nakazato. (2003) Somatostatin suppresses ghrelin secretion from the rat stomach. Biochemical and Biophysical Research Communications 302:3, pages 520-525.
Crossref
Carla Ripamonti & Eduardo Bruera. (2002) Palliative Management of Malignant Bowel Obstruction. International Journal of Gynecological Cancer 12:2, pages 135-143.
Crossref
P T J Emery, N B Higgs, A C Warhurst, G L Carlson & G Warhurst. (2002) Anti-secretory properties of non-peptide somatostatin receptor agonists in isolated rat colon: luminal activity and possible interaction with p-glycoprotein. British Journal of Pharmacology 135:6, pages 1443-1448.
Crossref
I. Hajdu, F. ObalJr.Jr., J. Fang, J. M. Krueger & C. D. Rollo. (2002) Sleep of transgenic mice producing excess rat growth hormone. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 282:1, pages R70-R76.
Crossref
Michel Afargan, Eva Tiensuu JansonGarry Gelerman, Rakefet Rosenfeld, Offer Ziv, Olga Karpov, Amnon WolfMoshe Bracha, Dvira Shohat, George LiapakisChaim GilonAmnon HoffmanDavid StephenskyKjell Oberg. (2001) Novel Long-Acting Somatostatin Analog with Endocrine Selectivity: Potent Suppression of Growth Hormone But Not of Insulin. Endocrinology 142:1, pages 477-486.
Crossref
Carla Ripamonti, Cristina Panzeri, Liliana Groff, Giordano Galeazzi & Roberto Boffi. (2018) The Role of Somatostatin and Octreotide in Bowel Obstruction: Pre-Clinic Al and Clinical Results. Tumori Journal 87:1, pages 1-9.
Crossref
Z AYDIN, E SAYIT, Y ERKIN, G ÇAPA, Y ERTAY, E SAĞIROĞLU & H DURAK. (2000) Effects of octreotide and morphine on the clearance rate of indium-111-pentetreotide from the epidural space. Nuclear Medicine Communications 21:9, pages 835-838.
Crossref
Ganesan Vaidyanathan, Donna Affleck, Philip Welsh, Ananth Srinivasan, Michelle Schmidt & Michael R Zalutsky. (2000) Radioiodination and astatination of octreotide by conjugation labeling. Nuclear Medicine and Biology 27:4, pages 329-337.
Crossref
Anne R Albers, M.Sue O’Dorisio, Douglas A Balster, Moonkyung Caprara, Pradip Gosh, Feng Chen, Carl Hoeger, Jean Rivier, Gail D Wenger, Thomas M O’Dorisio & Stephen J Qualman. (2000) Somatostatin receptor gene expression in neuroblastoma. Regulatory Peptides 88:1-3, pages 61-73.
Crossref
Mary Jane Heeg & Silvia S. Jurisson. (1999) The Role of Inorganic Chemistry in the Development of Radiometal Agents for Cancer Therapy. Accounts of Chemical Research 32:12, pages 1053-1060.
Crossref
L. Beranek, I. Hajdu, J. Gardi, P. Taishi, F. ObálJr.Jr. & J. M. Krueger. (1999) Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 277:5, pages R1297-R1304.
Crossref
Neal J. Meropol, Leslie E. Blumenson & Patrick J. Creaven. (1998) Octreotide Does Not Prevent Diarrhea in Patients Treated With Weekly 5-Fluorouracil Plus High-Dose Leucovorin. American Journal of Clinical Oncology 21:2, pages 135-138.
Crossref
Ying-Ta Wu, Hsing-Pang Hsieh, Chi-Yu Wu, Hui-Ming Yu, Shui-Tein Chen & Kung-Tsung Wang. (1998) Facile solid phase synthesis of octreotide analogs using p-carboxybenzaldehyde as a novel linker to anchor Fmoc-threoninol to solid phase resins. Tetrahedron Letters 39:13, pages 1783-1784.
Crossref
S. J. Mather. 1998. Clinical Nuclear Medicine. Clinical Nuclear Medicine 609 616 .
George ÖsapayLaszlo ProkaiHo-Seung KimKatalin F. MedzihradszkyDavid H. CoyGeorge LiapakisTerry ReisineGiuseppe MelaciniQin ZhuSusan H.-H. WangRalph-Heiko MatternMurray Goodman. (1997) Lanthionine−Somatostatin Analogs:  Synthesis, Characterization, Biological Activity, and Enzymatic Stability Studies. Journal of Medicinal Chemistry 40:14, pages 2241-2251.
Crossref
N DAVIES, J YATES, H KYNASTON, BA TAYLOR & SA JENKINS. (2008) Effects of octreotide on liver regeneration and tumour growth in the regenerating liver. Journal of Gastroenterology and Hepatology 12:1, pages 47-53.
Crossref
Pierre Martineau, Jill A. Shwed & Ronald Denis. (1996) Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?. The American Journal of Surgery 172:4, pages 386-395.
Crossref
Eiichi Ubukata, Osamu Mokuda, Yoshikazu Sakamoto & Naokata Shimizu. (1996) Effect of various glucagon/insulin molar ratios on blood ketone body levels in rats by use of osmotic minipumps. Diabetes Research and Clinical Practice 34:1, pages 1-6.
Crossref
Daniel Krois, Christina Riedel, Hermann Kalchhauser, Harald Lehner, Peter Angelberger & Irene Virgolini. (2006) Synthesis of N-α-(6-Hydrazinonicotinoyl)-Octreotide: A Precursor of a [99mTc] Complex. Liebigs Annalen 1996:9, pages 1463-1469.
Crossref
Artur J. de Brum‐Fernandes, Sophie Morisset, Ghassan Bkaily & Caroline Patry. (2012) Characterization of the PGE 2 receptor subtype in bovine chondrocytes in culture . British Journal of Pharmacology 118:7, pages 1597-1604.
Crossref
G. Fricker, A. Fahr, C. Beglinger, T. Kissel, G. Reiter & J. Drewe. (1996) Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations. British Journal of Pharmacology 117:1, pages 217-223.
Crossref
Jean-Luc Fauchère. 1996. Biochemical Technology. Biochemical Technology 569 583 .
Vicente Martínez, David H. Coy, K.C. Kent Lloyd & Yvette Taché. (1996) Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. European Journal of Pharmacology 296:2, pages 153-160.
Crossref
R. D. Penn. 1996. Zur Behandlung akuter und chronischer Schmerzen. Zur Behandlung akuter und chronischer Schmerzen 235 243 .
Deborah A. Martinez, M.Sue O'Dorisio, Thomas M. O'Dorisio, Stephen J. Qualman, Donna A. Caniano, Steven Teich, Gail E. Besner & Denis R. King. (1995) Intraoperative detection and resection of occult neuroblastoma: A technique exploiting somatostatin receptor expression. Journal of Pediatric Surgery 30:11, pages 1580-1589.
Crossref
Chee Kiat Tan, Prasad V. Podila, John E. Taylor, David M. Nagorney, Gregory A. Wiseman, Gregory J. Gores & Nicholas F. Larusso. (1995) Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology 108:6, pages 1908-1916.
Crossref
Sebastiano Mercadante. (1995) Octreotide in the treatment of diarrhoea induced by coeliac plexus block. Pain 61:2, pages 345-346.
Crossref
J. L. Fauchère. 1995. Computer Aided Drug Design in Industrial Research. Computer Aided Drug Design in Industrial Research 129 161 .
Alan G. Harris, Sam P. Kokoris & Shereen Ezzat. (2013) Continuous Versus Intermittent Subcutaneous Infusion of Octreotide in the Treatment of Acromegaly. The Journal of Clinical Pharmacology 35:1, pages 59-71.
Crossref
Sebastiano Mercadante. (1994) The role of octreotide in palliative care. Journal of Pain and Symptom Management 9:6, pages 406-411.
Crossref
Paul N. Maton. (1994) Expanding uses of octreotide. Baillière's Clinical Gastroenterology 8:2, pages 321-337.
Crossref
Andrew J. Krentz, Patrick J. Boyle, Linda M. Macdonald & David S. Schade. (1994) Octreotide: A long-acting inhibitor of endogenous hormone secretion for human metabolic investigations. Metabolism 43:1, pages 24-31.
Crossref
D. J. Hnatowich. 1994. Metal Compounds in Cancer Therapy. Metal Compounds in Cancer Therapy 215 247 .
H. Friess & M. W. Büchler. 1994. Facing the Pancreatic Dilemma. Facing the Pancreatic Dilemma 417 426 .
Sebastiano Mercadante, Elio Spoldi, Augusto Caraceni, Salvatore Maddaloni & Maria Teresa Simonetti. (2016) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliative Medicine 7:4, pages 295-299.
Crossref
Feng Chen, M.Sue O'Dorisio, Gerlinda Hermann, John Hayes, William B. Malarkey & Thomas M. O'Dorisio. (1993) Mechanisms of action of long-acting analogs of somatostatin. Regulatory Peptides 44:3, pages 285-295.
Crossref
J. M. KUHN, C. BASIN, M. MOLLARD, B. DE ROUGE, B. SCHATZ & L. M. WOLF. (2008) Effects of the new somatostatin analogue (BIM 23014) on blood glucose homeostasis in normal men. European Journal of Clinical Investigation 22:12, pages 793-799.
Crossref
Francis J. Dudley. (1992) Somatostatin and portal hypertensive bleeding: A safe therapeutic alternative?. Gastroenterology 103:6, pages 1973-1977.
Crossref
V. Chapman & A.H. Dickenson. (1992) The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord. Neuropeptides 23:3, pages 147-152.
Crossref
K Yasuda, S Rens-Domiano, C.D. Breder, S.F. Law, C.B. Saper, T Reisine & G.I. Bell. (1992) Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.. Journal of Biological Chemistry 267:28, pages 20422-20428.
Crossref
Paul N. Maton & R.T. Jensen. (1992) USE OF GUT PEPTIDE RECEPTOR AGONISTS AND ANTAGONISTS IN GASTROINTESTINAL DISEASES. Gastroenterology Clinics of North America 21:3, pages 551-566.
Crossref
Bart Van Ooijen, Cor J. Tinga, Wil J. Kort, Freek J. Zijlstra, Steven W. J. Lamberts & J. H. Paul Wilson. (1992) Effects of long-acting somatostatin analog (SMS 201-995) on eicosanoid synthesis and survival in rats with acute necrotizing pancreatitis. Digestive Diseases and Sciences 37:9, pages 1434-1440.
Crossref
Sebastiano Mercadante. (2016) Treatment of diarrhoea due to enterocolic fistula with octreotide in a terminal cancer patient. Palliative Medicine 6:3, pages 257-259.
Crossref
Stephanie Rens‐Domiano & Terry Reisine. (2006) Biochemical and Functional Properties of Somatostatin Receptors. Journal of Neurochemistry 58:6, pages 1987-1996.
Crossref
G. Flicker, J. Drewe, J. Vonderscher, T. Kissel & C. Beglinger. (2012) Enteral absorption of octreotide. British Journal of Pharmacology 105:4, pages 783-786.
Crossref
Richard D. Penn, Judith A. Paice & Jeffrey S. Kroin. (1992) Octreotide: a potent new non-opiate analgesic for intrathecal infusion. Pain 49:1, pages 13-19.
Crossref
Isabella J.E. Heuser, Fabio Baronti, Concepcion A. Marin, Ning Ma, George R. Merriam, T.N. Chase & M.Maral Mouradian. (1992) Growth hormone secretion in Alzheimer's disease: 24-Hour profile of basal levels and response to stimulation and suppression studies. Neurobiology of Aging 13:2, pages 255-260.
Crossref
Richard D. Penn. 1992. Advances in Pain Therapy I. Advances in Pain Therapy I 69 77 .
P. Pederzoli, M. Falconi, C. Bassi, L. Benetti & G. F. Briani. 1992. Pancreatic Fistulas. Pancreatic Fistulas 146 154 .
Richard N. Greenberg. (1991) Effects of somatostatin analog SMS 201-995 on enterotoxigenic diarrhea. Digestive Diseases and Sciences 36:12, pages 1768-1773.
Crossref
Roger D. Hurst & Irvin M. Modlin. (1991) The therapeutic role of octreotide in the management of surgical disorders. The American Journal of Surgery 162:5, pages 499-507.
Crossref
Gert Fricker, Christian Bruns, Johann Munzer, Ulrich Briner, Rainer Albert, Thomas Kissel & Jacky Vonderscher. (1991) Intestinal absorption of the octapeptide SMS 201–995 visualized by fluorescence derivatization. Gastroenterology 100:6, pages 1544-1552.
Crossref
M. Yoneda, H. Raybould & Y. Taché. (1991) Central action of somatostatin analog, SMS 201-995, to stimulate gastric acid secretion in rats. Peptides 12:3, pages 401-406.
Crossref
L. S. Miller, J. D. Gardner, J. Doppman & R. T. Jensen. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease 349 400 .
ANDREW V. SCHALLY, JOHN COLALUCA, DALE PAULSON, WELDON H. CARTER, HAL R. NEITZSCHMAN, HADEN LAFAYE & R.-Z. CAI. (2009) Effect of somatostatin analogs on gastric acid secretion in dogs and rats. International Journal of Peptide and Protein Research 36:3, pages 267-274.
Crossref
J.E. Fassler, T.M. O'Dorisio, H.S. Mekhjian & T.S. Gaginella. (1990) Octreotide inhibits increases in short-circuit current induced in rat colon by VIP, substance P, serotonin and aminophylline. Regulatory Peptides 29:2-3, pages 189-197.
Crossref
RichardD. Penn, JudithA. Paice & JeffreyS. Kroin. (1990) Intrathecal octreotide for cancer pain. The Lancet 335:8691, pages 738.
Crossref
Norman A. Mazer. (1990) Pharmacokinetic and pharmacodynamic aspects of polypeptide delivery. Journal of Controlled Release 11:1-3, pages 343-356.
Crossref
Daniel W. Green, Guillermo Gomez & George H. GreeleyJrJr. (1989) Gastrointestinal Peptides. Gastroenterology Clinics of North America 18:4, pages 695-733.
Crossref
Chantal WYNANTS, Dirk TOURWE, Wieslaw KAZMIERSKI, Victor J. HRUBY & Georges VAN BINST. (2005) Conformation of two somatostatin analogues in aqueous solution. European Journal of Biochemistry 185:2, pages 371-381.
Crossref
Witold Neugebauer & Emanuel Escher. (2004) Solid‐phase Synthesis of C‐Terminal Peptide Amino Alcohols. Helvetica Chimica Acta 72:6, pages 1319-1323.
Crossref
Paul N. Maton, Jerry D. Gardner & Robert T. Jensen. (1989) Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Digestive Diseases and Sciences 34:S3, pages S28-S39.
Crossref
D. P. D'Cruz, J. Reynard, A. J. Tatman & P. G. Kopelman. (1989) Long-term symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue.. Postgraduate Medical Journal 65:760, pages 116-117.
Crossref
D. Wynick, J.M. Polak & S.R. Bloom. (1989) Somatostatin and its analogues in the therapy of gastrointestinal disease. Pharmacology & Therapeutics 41:1-2, pages 353-370.
Crossref
F. László, I. Pávó, B. Penke & G.A. Bálint. (1989) Protective effect of an orally administered, highly potent somatostatin analog (RC-121) against absolute ethanol-induced hemorrhagic erosions of the rat gastric mucosa. Life Sciences 44:21, pages 1573-1578.
Crossref
M. J. Dunne, R. Elton, T. Fletcher, P. Hofker & J. Shui. 1989. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors 93 113 .
Jack M. Rosenberg. (1988) Octreotide: A Synthetic Analog of Somatostatin. Drug Intelligence & Clinical Pharmacy 22:10, pages 748-754.
Crossref
Y. NIITSU, Y. GOTO, M. MAEDA, N. TSUSHIMA, N. WATANABE, Y. KOHGO & I. URUSHIZAKI. (2007) Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995). Alimentary Pharmacology & Therapeutics 2:3, pages 269-279.
Crossref
D H Presky & A Schonbrunn. (1988) Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin.. Journal of Biological Chemistry 263:2, pages 714-721.
Crossref
R. G. LONG. (2007) Review: long‐acting somatostatin analogues. Alimentary Pharmacology & Therapeutics 1:3, pages 191-200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.